Vasovagal Syncope Clinical Trial
Official title:
Assessment of Stroke Volume and Cardiac Output in Response to Varying Heart Rates and Body Position - a Pacemaker Based Study
The investigators will seek to determine the effects of different heart rates on both stroke volume and cardiac output using non-invasive hemodynamic assessments. In order to safely manipulate the HR, the investigators will study patients with permanent pacemakers in whom heart rate manipulation can be done in a safe and non-invasive manner.
Permanent pacemakers have sometimes been used to treat patients with recurrent vasovagal syncope. This is because patients with vasovagal syncope often experience bradycardia at the time of their syncope. Unfortunately, pacemakers are often ineffective in preventing syncope. Classical cardiovascular hemodynamics would suggest that increasing the heart rate (HR; via pacemaker) should increase the cardiac output (CO). This is because: CO = HR x Stroke volume (SV). The assumption is that the SV is fixed during manipulation of the HR. However, this might not be the case. As the number of beats per minute (HR) increases, the cardiac cycle length (R-R interval [RRI]) shortens, as a function of simple math. This means that the time in cardiac systole shortens, and the time in cardiac diastole shortens. Since cardiac diastole is when the heart fills up with blood, faster HR can be associated with decreased cardiac filling times. This, in turn, could compromise the SV. However, there is a paucity of data as to what happens to SV and CO at different HR. Further, it is possible that these effects will be different when a person is lying down supine versus when a patient is upright (when stroke volume will be lower). The investigators will seek to determine the effects of different HR on both SV & CO. In order to safely manipulate the HR, they will study patients with permanent pacemakers in whom HR manipulation can be done in a safe and non-invasive manner. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05621460 -
The Effect of Water Carbonation on Orthostatic Tolerance
|
N/A | |
Active, not recruiting |
NCT02123056 -
Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects
|
Phase 4 | |
Completed |
NCT02140567 -
Syncope Prediction Study
|
||
Active, not recruiting |
NCT01456481 -
Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IV
|
Phase 4 | |
Completed |
NCT00061009 -
Hypnosis in Autonomic Function
|
N/A | |
Recruiting |
NCT06331819 -
Clinical Association Between Obstructive Sleep Apnea, Facial Pigmentation, and Vasovagal Symptoms.
|
||
Recruiting |
NCT05159687 -
Study of Atomoxetine in the Prevention of Vasovagal Syncope
|
Phase 3 | |
Completed |
NCT02500732 -
Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope
|
Phase 2 | |
Recruiting |
NCT02018497 -
Essential Hypotension and Allostasis Registry
|
||
Active, not recruiting |
NCT01791816 -
Mechanisms of Vasovagal Syncope
|
Early Phase 1 | |
Completed |
NCT00292825 -
Effect of Closed Loop Pacemaker Treatment on Recurrent Vasovagal Syncope
|
N/A | |
Completed |
NCT02636712 -
Observation of ImageReady™ MR Conditional Pacing System in China
|
||
Completed |
NCT02949804 -
Relation Between Vasovagal Tendency and Smoking Among University Students
|
N/A | |
Completed |
NCT02009982 -
Cardioneuroablation for Neurocardiogenic Syncope
|
N/A | |
Not yet recruiting |
NCT06166277 -
Cardioneuroablation for Recurrent Vasovagal Syncope and Bradyarrhythmias: The CNA-FWRD Registry
|